Your browser doesn't support javascript.
Safety and Feasibility of Thoracic Malignancy Surgery During the COVID-19 Pandemic.
Seitlinger, Joseph; Wollbrett, Christophe; Mazzella, Antonio; Schmid, Severin; Guerrera, Francesco; Banga Nkomo, Douglas; Hassan, Mohamed; Brindel, Aurélien; Ruuth-Praz, Julia; Schmitt, Pierre; Clément-Duchêne, Christelle; Douiri, Nawal; Reeb, Jérémie; Prisciandaro, Elena; Siat, Joelle; Spaggiari, Lorenzo; Ruffini, Enrico; Filosso, Pierluigi; Ferri, Lorenzo; Santelmo, Nicola; Spicer, Jonathan; Renaud, Stéphane.
  • Seitlinger J; Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France.
  • Wollbrett C; Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France.
  • Mazzella A; Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
  • Schmid S; Department of Thoracic Surgery, University Hospital Freiburg, Freiburg, Germany; Department of Thoracic Surgery and Upper Gastrointestinal Surgery, McGill University, Montreal, Canada.
  • Guerrera F; Thoracic Surgery Unit, University of Turin, Turin, Italy.
  • Banga Nkomo D; Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France.
  • Hassan M; Department of Thoracic Surgery, University Hospital Freiburg, Freiburg, Germany.
  • Brindel A; Chest Department, Nancy Regional University Hospital, Nancy, France.
  • Ruuth-Praz J; Chest Department, Nancy Regional University Hospital, Nancy, France.
  • Schmitt P; Chest Department, Sarreguemines Private Hospital, Sarreguemines, France.
  • Clément-Duchêne C; Department of Oncology, Lorraine Institute of Oncology, Nancy, France.
  • Douiri N; Department of Internal Medicine and Infectious Disease, Rhena Private Hospital, Strasbourg, France.
  • Reeb J; Department of Thoracic Surgery, Rhena Private Hospital, Strasbourg, France.
  • Prisciandaro E; Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
  • Siat J; Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France.
  • Spaggiari L; Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy.
  • Ruffini E; Thoracic Surgery Unit, University of Turin, Turin, Italy.
  • Filosso P; Thoracic Surgery Unit, University of Turin, Turin, Italy.
  • Ferri L; Department of Thoracic Surgery and Upper Gastrointestinal Surgery, McGill University, Montreal, Canada.
  • Santelmo N; Department of Thoracic Surgery, Rhena Private Hospital, Strasbourg, France.
  • Spicer J; Department of Thoracic Surgery and Upper Gastrointestinal Surgery, McGill University, Montreal, Canada.
  • Renaud S; Department of Thoracic Surgery, Nancy Regional University Hospital, Nancy, France. Electronic address: sterenaud0@gmail.com.
Ann Thorac Surg ; 112(6): 1870-1876, 2021 12.
Article in English | MEDLINE | ID: covidwho-973851
ABSTRACT

BACKGROUND:

The coronavirus disease 2019 (COVID-19) pandemic has decreased surgical activity, particularly in the field of oncology, because of the suspicion of a higher risk of COVID-19-related severe events. This study aimed to investigate the feasibility and safety of thoracic cancer surgery in the most severely affected European and Canadian regions during the COVID-19 pandemic.

METHODS:

The study investigators prospectively collected data on surgical procedures for malignant thoracic diseases from January 1 to April 30, 2020. The study included patients from 6 high-volume thoracic surgery departments Nancy and Strasbourg (France), Freiburg (Germany), Milan and Turin (Italy), and Montreal (Canada). The centers involved in this research are all located in the most severely affected regions of those countries. An assessment of COVID-19-related symptoms, polymerase chain reaction (PCR)-confirmed COVID-19 infection, rates of hospital and intensive care unit admissions, and death was performed for each patient. Every deceased patient was tested for COVID-19 by PCR.

RESULTS:

In the study period, 731 patients who underwent 734 surgical procedures were included. In the whole cohort, 9 cases (1.2%) of COVID-19 were confirmed by PCR, including 5 in-hospital contaminants. Four patients (0.5%) needed readmission for oxygen requirements. In this subgroup, 2 patients (0.3%) needed intensive care unit and mechanical ventilatory support. The total number of deaths in the whole cohort was 22 (3%). A single death was related to COVID-19 (0.14%).

CONCLUSIONS:

Maintaining surgical oncologic activity in the era of the COVID-19 pandemic seems safe and feasible, with very low postoperative morbidity or mortality. To continue to offer the best care to patients who do not have COVID-19, reports on other diseases are urgently needed.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thoracic Neoplasms / Thoracic Surgical Procedures / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Thorac Surg Year: 2021 Document Type: Article Affiliation country: J.athoracsur.2020.12.001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thoracic Neoplasms / Thoracic Surgical Procedures / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Thorac Surg Year: 2021 Document Type: Article Affiliation country: J.athoracsur.2020.12.001